h-Caldesmon, Calretinin, Estrogen Receptor, and Ber-EP4: A Useful Combination of Immunohistochemical Markers for Differentiating Epithelioid Peritoneal Mesothelioma From Serous Papillary Carcinoma of the Ovary-Reference-Cited by-同舟云学术

h-Caldesmon, Calretinin, Estrogen Receptor, and Ber-EP4: A Useful Combination of Immunohistochemical Markers for Differentiating Epithelioid Peritoneal Mesothelioma From Serous Papillary Carcinoma of the Ovary

Published:2007-08 Issue:8 Volume:31 Page:1139-1148
ISSN:0147-5185
Container-title:American Journal of Surgical Pathology
language:en
Short-container-title:

Author:

Comin Camilla E.,Saieva Calogero,Messerini Luca

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pathology and Forensic Medicine,Surgery,Anatomy

Reference50 articles.

1. Lymphatic invasion using D2-40 monoclonal antibody and its relationship to lymph node micrometastasis in pN0 gastric cancer;Arigami;Br J Cancer,2005

2. Thrombomodulin expression in malignant peritoneal mesothelioma and serous papillary adenocarcinoma of the ovary;Attanoos;J Pathol,1995

3. Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum;Attanoos;Histopathology,2002

4. BRCA1 gene mutations in women with papillary serous carcinoma of the peritoneum;Bandera;Obstet Gynecol,1998

5. Comparison between primary peritoneal and epithelial ovarian carcinoma: a population-based study;Barda;Am J Obstet Gynecol,2004

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Uterine mesothelial cysts mimicking ovarian cysts in a primipara patient with a history of Cesarean section: A case report and review of the literature;Taiwanese Journal of Obstetrics and Gynecology;2024-05

2. Peritoneum and Broad Ligament;Gynecologic and Obstetric Pathology;2024

3. The Role of Cytology in the Management of Ovarian Lesions;Essentials of Diagnostic Gynecological Pathology;2023

4. BAP1 and Claudin-4, But Not MTAP, Reliably Distinguish Borderline and Low-grade Serous Ovarian Tumors From Peritoneal Mesothelioma;International Journal of Gynecological Pathology;2022-05-20

5. Ovary;Handbook of Practical Immunohistochemistry;2022